Massachusetts General Hospital
Boston, Massachusetts, 02129, United States
NCT Number: NCT04059952
This is an observational neuroimaging study assessing the effects of ECT on the brains of patients with unipolar and bipolar depression.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Boston, Massachusetts, 02129, United States
This project aims to use functional connectivity magnetic resonance imaging (fcMRI) to study patients with unipolar and bipolar depression receiving ECT. Patients will be scanned before and after a full course of ECT and clinical measures for depression severity and memory will be obtained at the same times.The project has the following aims and hypothesis: (1) to determine the therapeutic antidepressant mechanism of action of ECT at the circuit level (2) to determine the mechanism of action of iatrogenic amnesia caused by ECT at the circuit level (3) to study the use of fcMRI as a state biomarker for depression (4) to study the use of fcMRI as a predictor of response for depression.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Electrical currents are passed through the brain to intentionally trigger a controlled seizure in order to produce a therapeutic change in neuro-chemistry and circuitry.
Time frame: Through Treatment Completion, Average of 2 Months
Measured by Magnetic Resonance Imaging, Key Nodes include Subgenual Cingulate, Dorsal Anterior Cingulate, Nucleus Accumbens, Hippocampus, Amygdala and Dorsolateral Prefrontal Cortex
Time frame: Through Treatment Completion, Average of 2 Months
Measured by Magnetic Resonance Imaging, Memory Circuits Include Hippocampus and Dorsolateral Prefrontal Memory Hubs
Massachusetts General Hospital
Other
Acronym: MoA-ECT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04939649
Bipolar Depression, Bipolar Disorder
Dublin, Ireland
View Trial DetailsNCT06126198
Bipolar Depression, Bipolar Disorder
Uppsala, Sweden
View Trial DetailsNCT03711019
Behavior, Behavioral Symptoms
Vancouver, British Columbia, Canada
View Trial DetailsNCT04420793
Bipolar Depression, Bipolar Disorder
Charleston, South Carolina, United States
View Trial Details